| Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues P Lundquist, P Artursson Advanced drug delivery reviews 106, 256-276, 2016 | 436 | 2016 |
| The proteome of filter-grown Caco-2 cells with a focus on proteins involved in drug disposition M Ölander, JR Wiśniewski, P Matsson, P Lundquist, P Artursson Journal of pharmaceutical sciences 105 (2), 817-827, 2016 | 77 | 2016 |
| Type II Na+-Pi Cotransporters in Osteoblast Mineral Formation: Regulation by Inorganic Phosphate P Lundquist, H Murer, J Biber Cellular Physiology and biochemistry 19 (1-4), 43-56, 2007 | 62 | 2007 |
| A protocol for polymerase chain reaction detection of Enterococcus faecalis and Enterococcus faecium from the root canal A Molander, P Lundquist, PN Papapanou, G Dahlén, C Reit International endodontic journal 35 (1), 1-6, 2002 | 54 | 2002 |
| Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition P Lundquist, G Englund, C Skogastierna, J Lööf, J Johansson, ... Drug Metabolism and Disposition 42 (3), 448-458, 2014 | 53 | 2014 |
| Global variability analysis of mRNA and protein concentrations across and within human tissues C Wegler, M Ölander, JR Wiśniewski, P Lundquist, K Zettl, A Åsberg, ... NAR Genomics and Bioinformatics 2 (1), lqz010, 2020 | 52 | 2020 |
| Cytochrome p450 inhibitory properties of common efflux transporter inhibitors G Englund, P Lundquist, C Skogastierna, J Johansson, J Hoogstraate, ... Drug Metabolism and Disposition 42 (3), 441-447, 2014 | 48 | 2014 |
| A CRISPR-Cas9 generated MDCK cell line expressing human MDR1 without endogenous canine MDR1 (cABCB1): an improved tool for drug efflux studies M Karlgren, I Simoff, M Backlund, C Wegler, M Keiser, N Handin, J Müller, ... Journal of pharmaceutical sciences 106 (9), 2909-2913, 2017 | 45 | 2017 |
| The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions P Lundquist, J Lööf, AK Sohlenius-Sternbeck, E Floby, J Johansson, ... Drug Metabolism and Disposition 42 (3), 469-480, 2014 | 45 | 2014 |
| The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers N Shrestha, O Bouttefeux, K Vanvarenberg, P Lundquist, J Cunarro, ... Nanoscale 10 (2), 603-613, 2018 | 43 | 2018 |
| The nptA Gene of Vibrio cholerae Encodes a Functional Sodium-Dependent Phosphate Cotransporter Homologous to the Type II Cotransporters of Eukaryotes M Lebens, P Lundquist, L Söderlund, M Todorovic, NIA Carlin Journal of bacteriology 184 (16), 4466-4474, 2002 | 42 | 2002 |
| Phosphate and calcium uptake by rat odontoblast‐like MRPC‐1 cells concomitant with mineralization P Lundquist, HH Ritchie, K Moore, T Lundgren, A Linde Journal of Bone and Mineral Research 17 (10), 1801-1813, 2002 | 38 | 2002 |
| Quantifying the impact of transporters on cellular drug permeability P Matsson, LA Fenu, P Lundquist, JR Wiśniewski, M Kansy, P Artursson Trends in Pharmacological Sciences 36 (5), 255-262, 2015 | 36 | 2015 |
| Na+/Ca2+ Exchanger Isoforms of Rat Odontoblasts and Osteoblasts P Lundquist, T Lundgren, A Gritli-Linde, A Linde Calcified tissue international 67, 60-67, 2000 | 30 | 2000 |
| Odontoblast phosphate and calcium transport in dentinogenesis. P Lundquist Swedish Dental Journal. Supplement, 1-52, 2002 | 27 | 2002 |
| Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model P Lundquist, J Lööf, U Fagerholm, I Sjögren, J Johansson, S Briem, ... Drug Metabolism and Disposition 42 (3), 459-468, 2014 | 17 | 2014 |
| A new opening for orally taken peptide drugs P Artursson, P Lundquist Nature Biomedical Engineering 4 (1), 12-13, 2020 | 12 | 2020 |
| Barriers to the intestinal absorption of four insulin-loaded arginine-rich nanoparticles in human and rat P Lundquist, G Khodus, Z Niu, LN Thwala, F McCartney, I Simoff, ... ACS nano 16 (9), 14210-14229, 2022 | 11 | 2022 |
| Addendum to ‘Quantifying the impact of transporters on cellular drug permeability’ P Matsson, LA Fenu, P Lundquist, JR Wiśniewski, M Kansy, P Artursson Trends in Pharmacological Sciences 36 (9), 559, 2015 | 5 | 2015 |
| The need for speed–kinetic limits of drug transporters P Matsson, P Lundquist, P Artursson Trends in Pharmacological Sciences 37 (4), 243-245, 2016 | 2 | 2016 |
Pär MatssonProfessor of Pharmacokinetics, Sahlgrenska Academy, University of Gothenburg在 gu.se 的电子邮件经过验证
Pär MatssonProfessor of Pharmacokinetics, Sahlgrenska Academy, University of Gothenburg在 gu.se 的电子邮件经过验证